1. J.R. Weeks, J.R. Schultz, and W.E. Brown, Evaluation of Smooth muscle bioassays for prostaglandins E1 and F1, J. Appl. Physiol. 25: 783 (1968).
2. J.H. Fleisch, L.E. Rinkema, K.D. Haisch, D. Swanson-Bean, T. Goodson, P.P.K. Ho, and W.S. Marshall, LY171883, 1-<-2-Hydroxy-3-Propyl-4-L4-(l-H-Tetrazol-5-yl) butoxy > phenyl > ethanone, an orally active leukotriene D4 antagonist, J. Pharmacol. Exp. Ther. 233: 148 (1985).
3. A.J. Januskiewicz and M.D. Faiman, The effect of in vivo hyperoxic exposure on the release of endogenous histamine from the rat isolated perfused lung, Toxicol. Appl. Pharmacol. 72: 134 (1984).
4. O.C. Burghuber, R.J. Strife, J. Zirrolli, P.M. Henson, J.E. Henson, M. Mathias, J.T. Reeves, R.C. Murphy, and N.F. Voelkel, Leukotriene inhibitors attenuate rat lung injury induced by hydrogen peroxide, Am. Rev. Respir. Pis. 131: 778 (1985).